These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Dantrolene sodium in the management of patients at risk from malignant hyperthermia. Bronstein SL; Ryan DE; Solomons CC; Mahowald MC J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734 [TBL] [Abstract][Full Text] [Related]
8. Malignant hyperthermia during a laparoscopic operation. Watari A; Kobori H; Yamamoto T J Minim Invasive Gynecol; 2011; 18(6):809-11. PubMed ID: 22024269 [TBL] [Abstract][Full Text] [Related]
16. [New findings and experiences in the field of malignant hyperthermia]. Schulte-Sasse U; Eberlein HJ Anaesthesist; 1986 Jan; 35(1):1-9. PubMed ID: 2938519 [TBL] [Abstract][Full Text] [Related]
17. Current understanding of malignant hyperthermia: genesis, prevention, and treatment. Katz DN CRNA; 1992 May; 3(2):54-63. PubMed ID: 1483145 [TBL] [Abstract][Full Text] [Related]
18. [Dantrolene. Pharmacological and therapeutic aspects]. Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006 [TBL] [Abstract][Full Text] [Related]
19. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report. Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374 [TBL] [Abstract][Full Text] [Related]